Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2017 08:23 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock

PRINCETON, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced the pricing of its underwritten public...
August 02, 2017 16:05 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Announces Proposed Offering of Common Stock

PRINCETON, N.J., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced that it intends to offer and sell shares of...
July 28, 2017 07:30 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Reports Second Quarter 2017 Financial Results

Cash Expected to Fund Operations into Q2 2018 FDA Assigns Prescription Drug User Fee Act (PDUFA) Goal Date of December 26, 2017 PRINCETON, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Agile...
July 27, 2017 16:11 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

PRINCETON, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced that the U.S. Food and Drug Administration...